JPWO2024100919A5 - - Google Patents

Info

Publication number
JPWO2024100919A5
JPWO2024100919A5 JP2024557017A JP2024557017A JPWO2024100919A5 JP WO2024100919 A5 JPWO2024100919 A5 JP WO2024100919A5 JP 2024557017 A JP2024557017 A JP 2024557017A JP 2024557017 A JP2024557017 A JP 2024557017A JP WO2024100919 A5 JPWO2024100919 A5 JP WO2024100919A5
Authority
JP
Japan
Prior art keywords
acid
moiety
agent according
sphingosine
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557017A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024100919A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/022157 external-priority patent/WO2024100919A1/ja
Publication of JPWO2024100919A1 publication Critical patent/JPWO2024100919A1/ja
Publication of JPWO2024100919A5 publication Critical patent/JPWO2024100919A5/ja
Pending legal-status Critical Current

Links

JP2024557017A 2022-11-11 2023-06-14 Pending JPWO2024100919A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022181327 2022-11-11
PCT/JP2023/022157 WO2024100919A1 (ja) 2022-11-11 2023-06-14 スフィンゴイド塩基を含む掻痒抑制に用いるための剤およびその用途

Publications (2)

Publication Number Publication Date
JPWO2024100919A1 JPWO2024100919A1 (https=) 2024-05-16
JPWO2024100919A5 true JPWO2024100919A5 (https=) 2025-12-16

Family

ID=91032082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557017A Pending JPWO2024100919A1 (https=) 2022-11-11 2023-06-14

Country Status (3)

Country Link
JP (1) JPWO2024100919A1 (https=)
CN (1) CN120112282A (https=)
WO (1) WO2024100919A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003378A (ja) * 2000-06-22 2002-01-09 Kanebo Ltd 外用抗掻痒剤
JP4383427B2 (ja) * 2006-05-16 2009-12-16 株式会社スリービー 皮膚保湿剤および皮膚炎治療剤
JPWO2016021573A1 (ja) * 2014-08-04 2017-05-25 株式会社明治 角層細胞共有結合セラミドの産生促進剤

Similar Documents

Publication Publication Date Title
JP5167273B2 (ja) αガラクトシルセラミド誘導体、その薬学的に許容可能な塩、その製造方法及びそれを有効成分として含む免疫補助用薬学的組成物
CN1152871C (zh) 用于增强分子伴娘素产生的羟胺衍生物及其制备
CN1358191A (zh) N-吡唑a2a受体激动剂
Turgeon et al. Epigenetics of Cardiovascular Disease: A New ‘Beat'in Coronary Artery Disease
JP2021526528A5 (https=)
CN102984939A (zh) 氘化的n-乙基-n-苯基-1,2-二氢-4-羟基-5-氯-1-甲基-2-氧代喹啉-3-甲酰胺、其盐和用途
JP2009501198A5 (https=)
JPWO2024100919A5 (https=)
JP2009543799A5 (https=)
Parashar et al. N6-adenine DNA methylation demystified in eukaryotic genome: From biology to pathology
Wu et al. Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase
JP2024525128A (ja) 試料採取システム
JP2005508872A5 (https=)
US20180002759A1 (en) Method of predicting a predisposition to qt prolongation
JP2009532434A5 (https=)
US10150733B2 (en) Amidoheteroaryl aroyl hydrazide ethynes
JP2013504313A5 (https=)
JP2017519000A (ja) グルカゴンアンタゴニスト
TW201012816A (en) Method of treatment and pharmaceutical compositions
JPWO2019238970A5 (https=)
JP2022184823A5 (https=)
JP2008513036A5 (https=)
JP2023136725A5 (https=)
JP2017514842A5 (https=)
JP2024114037A5 (https=)